Bilateral cavernosus sinus thrombosis in a patient with periodontal disease and diabetes mellitus. description of a case
Main Article Content
Abstract
Cavernous sinus thrombosis is a vascular disease with an unusual presentation, associated with high morbidity, mortality and neurological sequelae. The most frequent etiological cause are the infectious processes at the head and neck level, being the gateway for different microorganisms that generate an inflammatory response that triggers the thrombotic event. Periodontal disease characterized by gingival inflammation, loss of surrounding connective tissue and eventual exfoliation of the tooth, is associated with the development of systemic diseases due to periodontal pathogens and inflammatory mediators that spread and produce complications due to contiguity such asthrombotic events in the central nervous system. We present the clinical case of a patient who developed a bilateral cavernous sinus thrombosis after undergoing a periodontal procedure.
Downloads
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
References
Dinkin M, Patsalides A, Ertel M. Diagnosis and Management of Cerebral Venous Diseases in Neuro-Ophthalmology: Ongoing Controversies. Asia-Pacific Journal of Ophthalmology. 2019; 8(1): 73-85. Doi: http://dx.doi.org/10.22608/APO.2018239
Cho JY, Kim HM, Ryu JY. Cavernous sinus thrombosis progression from trismus. Journal of the Korean Association Oral and Maxillofacial Surgeons. 2015; 41(1): 43-7. Doi: http://dx.doi.org/10.5125/jkaoms.2015.41.1.43
Guenther G, Arauz A. Trombosis venosa cerebral: aspectos actuales del diagnóstico y tratamiento. Neurología. 2011; 26(8): 488-98. Doi: http://dx.doi.org/10.1016/j.nrl.2010.09.013
Khatri IA, Wasay M. Septic cerebral venous sinus thrombosis. Journal of the Neurological Sciences. 2016; 362: 221-7. Doi: http://dx.doi.org/10.1016/j.jns.2016.01.035
Desa V, Green R. Cavernous Sinus Thrombosis: Current Therapy. Journal of Oral and Maxillofacial Surgery. 2012; 70(9): 2085-91. Doi: http://dx.doi.org/10.1016/j.joms.2011.09.048
Hsu CW, Tsai WC, Lien CY, Lee JJ, Chang WN. The clinical characteristics, implicated pathogens and therapeutic outcomes of culture-proven septic cavernous sinus thrombosis. Journal of Clinical Neuroscience. 2019; 68: 111-6. Doi: http://dx.doi.org/10.1016/j.jocn.2019.07.022
Bhatia H, Kaur R, Bedi R. MR imaging of cavernous sinus thrombosis. European Journal of Radiology Open. 2020; (7): 100226. Doi: http://dx.doi.org/10.1016/j.ejro.2020.100226
Bui FQ, Coutinho CL, Huynh B, Trinh A, Liu J, Woodward J, et al. Association between periodontal pathogens and systemic disease. Biomedical Journal. 2018; 42(1): 27-35. Doi: http://dx.doi.org/10.1016/j.bj.2018.12.001
Mahalingam HV, Mani S, Patel B, Prabhu K, Alexander M, Fatterpekar G, et al. Imaging Spectrum of Cavernous Sinus Lesions with Histopathologic Correlation. Radiographics. 2019; 39(3): 795-819. Doi: http://dx.doi.org/10.1148/rg.2019180122
Gallagher JP. Septic thrombosis of the cavernous sinus. The Medical Annals of the District of Columbia. 1960; 29: 278-83. Available at: https://pubmed.ncbi.nlm.nih.gov/13826082/
Hsu YJ, Lin KD, Chen JH, Lee MY, Lin YC, Yen FC, et al. Periodontal Treatment Experience Associated with Oral Health-Related Quality of Life in Patients with Poor Glycemic Control in Type 2 Diabetes: A Case-Control Study. International Journal of Environmental Research ans Public Health. 2019; 16(20): 4011. Doi: http://dx.doi.org/10.3390/ijerph16204011
Rohani B. Oral manifestation in patients with diabetes mellitus. World Journal of Diabetes. 2019; 10(9): 485-9. Doi: http://dx.doi.org/10.4239/wjd.v10.i9.485
Colbert S, Cameron M, Williams J. Septic thrombosis of the cavernous sinus and dental infection. British Journal of Oral and Maxillofacial Surgery. 2011; 49(6): e25-e26. Doi: http://dx.doi.org/10.1016/j.bjoms.2010.07.004
Critchley JA, Carey IN, Harris T, Dewilde S, Hosking D, Cook D, et al. Glycemic Control and Risk of Infections Among People With Type 1 or Type 2 Diabetes in a Large Primary Care Cohort Study. Diabetes Care. 2018; 41(10): 2127-35. Doi: http://dx.doi.org/10.2337/dc18-0287
Rajagopalan S. Serious Infections in Elderly Patients with Diabetes Mellitus. Clinical Infectious Diseases. 2005; 40(7): 990-6. Doi: http://dx.doi.org/10.1086/427690
Bhatia K, Jones NS. Septic cavernous sinus thrombosis secondary to sinusitis : are anticoagulants indicated ? A review of the literature. The Journal of Laryngology and Otology. 2017; 116(9): 667-76. Doi: http://dx.doi.org/10.1258/002221502760237920
Xu W, Gao L, Li T, Shao A, Zhang J. Efficacy and risks of anticoagulation for cerebral venous thrombosis. Medicine Baltimore. 2018; 97(20): e10506. Doi: http://dx.doi.org/10.1097/MD.0000000000010506
Coutinho J, de Bruijn SF, Deveber G, Stam J. Anticoagulation for cerebral venous sinus thrombosis. The Cochrane Database of Systematic Reviews. 2011; 2011(8): CD002005. Doi: http://dx.doi.org/10.1002/14651858.cd002005.pub2